Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Elens

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Pharmacogenomics|December 21, 2012
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapyLaure Elens, Teun van Gelder, Dennis A Hesselink, et al.
Pharmacogenetics and Genomics|October 12, 2013
Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimusLaure Elens, Ferdi Sombogaard, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|March 31, 2016
Genetic Predisposition to Poor Opioid Response in Preterm Infants: Impact of KCNJ6 and COMT Polymorphisms on Pain Relief After Endotracheal IntubationLaure Elens, Elisabeth Norman, Maja Matic, et al.
Pharmacogenetics and Genomics|October 27, 2011
Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular dispositionLaure Elens, Donatienne Tyteca, Nadtha Panin, et al.
Pharmacogenomics|December 19, 2014
POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemiaEuridiki Drogari, Georgia Ragia, Vasiliki Mollaki, et al.
Research and Practice in Thrombosis and Haemostasis|September 4, 2024
<i>In vitro</i> assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell linesGwenaëlle Mahieu, Anne-Laure Sennesael, Lionel Pochet, et al.
British Journal of Clinical Pharmacology|October 15, 2013
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocksLaure Elens, Rachida Bouamar, Nauras Shuker, et al.
Pharmacogenetics and Genomics|March 6, 2012
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Plos One|October 28, 2016
Interaction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 PolymorphismLeïla Belkhir, Laure Elens, Francis Zech, et al.
Scientific Reports|April 27, 2021
Effect of four ABCB1 genetic polymorphisms on the accumulation of darunavir in HEK293 recombinant cell linesGabriel Stillemans, Happy Phanio Djokoto, Kévin-Alexandre Delongie, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Pharmacogenomics|December 21, 2012
CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapyLaure Elens, Teun van Gelder, Dennis A Hesselink, et al.
Pharmacogenetics and Genomics|October 12, 2013
Single-nucleotide polymorphisms in P450 oxidoreductase and peroxisome proliferator-activated receptor-α are associated with the development of new-onset diabetes after transplantation in kidney transplant recipients treated with tacrolimusLaure Elens, Ferdi Sombogaard, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|March 31, 2016
Genetic Predisposition to Poor Opioid Response in Preterm Infants: Impact of KCNJ6 and COMT Polymorphisms on Pain Relief After Endotracheal IntubationLaure Elens, Elisabeth Norman, Maja Matic, et al.
Pharmacogenetics and Genomics|October 27, 2011
Functional defect caused by the 4544G>A SNP in ABCC2: potential impact for drug cellular dispositionLaure Elens, Donatienne Tyteca, Nadtha Panin, et al.
Pharmacogenomics|December 19, 2014
POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemiaEuridiki Drogari, Georgia Ragia, Vasiliki Mollaki, et al.
Research and Practice in Thrombosis and Haemostasis|September 4, 2024
<i>In vitro</i> assessment of the risk of ABCB1-mediated drug-drug interaction between rivaroxaban and tacrolimus in human embryonic kidney 293 recombinant cell linesGwenaëlle Mahieu, Anne-Laure Sennesael, Lionel Pochet, et al.
British Journal of Clinical Pharmacology|October 15, 2013
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocksLaure Elens, Rachida Bouamar, Nauras Shuker, et al.
Pharmacogenetics and Genomics|March 6, 2012
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
Plos One|October 28, 2016
Interaction between Darunavir and Etravirine Is Partly Mediated by CYP3A5 PolymorphismLeïla Belkhir, Laure Elens, Francis Zech, et al.
Scientific Reports|April 27, 2021
Effect of four ABCB1 genetic polymorphisms on the accumulation of darunavir in HEK293 recombinant cell linesGabriel Stillemans, Happy Phanio Djokoto, Kévin-Alexandre Delongie, et al.
Pageof 9